Delcath Systems Provides Speaker List for Dec 2, 2021 Investor Update Meeting
Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, announced today its agenda and distinguished speaker list for a comprehensive Investor Update Meeting taking place Thursday, December 2nd , from 10:00am ET – 1:30pm EST. The event will focus on the company’s US product candidate,… Read More